The coronavirus disease has increased the risk of human-to-human transmission of respiratory droplets coupled with a high level of population mobility, and has resulted in a rapid dissemination worldwide. This has increased the role of healthcare facilities and stakeholders in the global interventional pulmonology market. With a high number of active COVID-19 cases in Singapore, India, Canada, and Pakistan, interventional pulmonologists (IP) are also being exposed to the risk of infection. Hence, companies in the interventional pulmonology market are maintaining robust supply chains of devices, medications, catheters, and stents, among others, to reduce the vulnerability of healthcare systems.
Similar to other open airway procedures or aerosol-generating procedures, bronchoscopy poses a significant risk of spreading contaminated droplets. Interventional pulmonologists are adapting to such high-risk procedures in order to ensure the safety of patients and other medical workers. Since there is a high risk of contracting the novel infection even after two doses of vaccination, interventional pulmonologists and related stakeholders in the value chain are maintaining optimum medical services to improve clinical outcomes.
Request a sample to get extensive insights into the Interventional Pulmonology Market
The interventional pulmonology market is projected to surpass US$ 8 Bn by 2031. Lung cancer diagnosis, staging, and management of the pulmonary nodule contribute to a significant portion of an IP’s work. Since lung cancer screening programs are surging in many parts of the world, it is highly possible that the workload of IPs will increase in the future. However, targeting the peripheral pulmonary nodule as well as accurate mediastinal staging is a daily challenge for the IP workforce. In order to tide over these challenges, stakeholders are mainly focusing on personalized medicine, targeted therapies, and collaboration among IP, medical oncology, and pathology to ensure patient quality of life (QOL).
To understand how our report can bring difference to your business strategy, Ask for a brochure
Robotic bronchoscopy is emerging as a game changer in the interventional pulmonology market. This explains why the market is estimated to register a striking CAGR of 8.7% during the forecast period. Companies are expected to collaborate with researchers to innovate in novel robotic bronchoscopy platforms that allow pulmonologists to clearly see and reach lung nodules without invasive surgery.
Rapid and accurate diagnosis of lung cancer have become the need of the hour in the interventional pulmonology market. This has triggered developments in robotic bronchoscopy platforms, which consist of a hand-held controller used to direct a small, flexible endoscope into the lung using a computer-assisted navigation. In this platform, the camera allows the physician to view a magnified image of the lung, which helps to deliver rapid and accurate diagnosis of lung cancer.
Inorganic business strategies such as mergers & acquisitions are growing prominent in the interventional pulmonology market. Olympus Corporation - a Japan-based manufacturer of optics and reprography products has announced the acquisition of Veran Medical Technologies, Inc. - a medical equipment manufacturer in Overland, Missouri, in order to expand its respiratory portfolio. Competitor companies in the interventional pulmonology market are determined to focus and scale their therapeutic solutions division to gain an edge over other market players. North America holds lucrative opportunities to accelerate processes and provide agility in the pulmonology therapeutics division.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Interventional Pulmonology Market
Analysts’ Viewpoint
IPs are adapting to new processes amid the ongoing coronavirus outbreak by adhering to a set of recommendations on how to perform bronchoscopy or pleural procedures safely to avoid contracting the infection. Navigational platforms and proprietary devices by companies are accelerating care in the lung cancer therapeutics division. However, in many cases, cancerous nodules in the lungs can be small and found in hard-to-reach areas, thus making biopsies difficult. Hence, companies in the interventional pulmonology market should increase their R&D activities in robotic pulmonary platforms to help IPs attain a magnified view of the lungs during the procedures.
Interventional Pulmonology Market – Segmentation
| Product Type |
|
| Indication |
|
| End User |
|
| Region |
|
Interventional pulmonology market is projected to surpass US$ 8 Bn by 2031
Interventional pulmonology market is projected to expand at a CAGR of ~9% from 2021 to 2031
Interventional pulmonology market is driven by rise in prevalence of respiratory disorders, increase in geriatric population, and surge in incidence of diseases that require endoscopic ultrasound procedures
North America is anticipated to account for a leading share of the global interventional pulmonology market during the forecast period
Key players operating in the global interventional pulmonology market are Argon Medical, Body Vision Medical Ltd., Boston Scientific Corporation, C. R. Bard, Inc. (Becton, Dickinson and Company), CONMED Corporation, Cook, ENDO-FLEX GmbH, Fujifilm Corporation, KARL STORZ SE & Co. KG
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Interventional Pulmonology Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Interventional Pulmonology Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
5. Key Insights
5.1. Regulatory Scenario by Region/globally
5.2. Key Industry Events
5.3. Disease Prevalence & Incidence Rate globally with key countries
5.4. COVID-19 Impact Analysis
5.5. Volume (No. of Procedures)
6. Global Interventional Pulmonology Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Product Type, 2017–2031
6.3.1. Bronchoscopes
6.3.1.1. Flexible Bronchoscopes
6.3.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)
6.3.2. Electromagnetic Navigation Bronchoscopy Systems
6.3.3. Pleuroscopes
6.3.4. Respiratory Endotherapy Devices
6.3.4.1. Aspiration Needles
6.3.4.2. Biopsy Forceps
6.3.4.3. Biopsy Brush
6.3.4.4. Biopsy Needles
6.3.4.5. Drainage Catheter
6.3.4.6. Pulmonary Catheter
6.3.4.7. Balloon Dilatation Catheter
6.3.4.8. Others (airway retrieval basket, airway suction catheter)
6.3.5. Airway Stents
6.3.6. Pleural Catheters
6.3.7. Endobronchial Valves
6.3.8. Bronchial Thermoplasty Systems
6.4. Market Attractiveness Analysis, by Product Type
7. Global Interventional Pulmonology Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. Asthma
7.3.2. COPD
7.3.3. Lung Cancer
7.3.4. Tracheal & Bronchial Stenosis
7.3.5. Others
7.4. Market Attractiveness Analysis, by Indication
8. Global Interventional Pulmonology Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Diagnostic Centers
8.3.4. Specialty Clinics
8.3.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Interventional Pulmonology Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Interventional Pulmonology Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product Type, 2017–2031
10.2.1. Bronchoscopes
10.2.1.1. Flexible Bronchoscopes
10.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)
10.2.2. Electromagnetic Navigation Bronchoscopy Systems
10.2.3. Pleuroscopes
10.2.4. Respiratory Endotherapy Devices
10.2.4.1. Aspiration Needles
10.2.4.2. Biopsy Forceps
10.2.4.3. Biopsy Brush
10.2.4.4. Biopsy Needles
10.2.4.5. Drainage Catheter
10.2.4.6. Pulmonary Catheter
10.2.4.7. Balloon Dilatation Catheter
10.2.4.8. Others (airway retrieval basket, airway suction catheter)
10.2.5. Airway Stents
10.2.6. Pleural Catheters
10.2.7. Endobronchial Valves
10.2.8. Bronchial Thermoplasty Systems
10.3. Market Value Forecast, by Indication, 2017–2031
10.3.1. Asthma
10.3.2. COPD
10.3.3. Lung Cancer
10.3.4. Tracheal & Bronchial Stenosis
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Diagnostic Centers
10.4.4. Specialty Clinics
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Interventional Pulmonology Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product Type, 2017–2031
11.2.1. Bronchoscopes
11.2.1.1. Flexible Bronchoscopes
11.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)
11.2.2. Electromagnetic Navigation Bronchoscopy Systems
11.2.3. Pleuroscopes
11.2.4. Respiratory Endotherapy Devices
11.2.4.1. Aspiration Needles
11.2.4.2. Biopsy Forceps
11.2.4.3. Biopsy Brush
11.2.4.4. Biopsy Needles
11.2.4.5. Drainage Catheter
11.2.4.6. Pulmonary Catheter
11.2.4.7. Balloon Dilatation Catheter
11.2.4.8. Others (airway retrieval basket, airway suction catheter)
11.2.5. Airway Stents
11.2.6. Pleural Catheters
11.2.7. Endobronchial Valves
11.2.8. Bronchial Thermoplasty Systems
11.3. Market Value Forecast, by Indication, 2017–2031
11.3.1. Asthma
11.3.2. COPD
11.3.3. Lung Cancer
11.3.4. Tracheal & Bronchial Stenosis
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Diagnostic Centers
11.4.4. Specialty Clinics
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Interventional Pulmonology Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product Type, 2017–2031
12.2.1. Bronchoscopes
12.2.1.1. Flexible Bronchoscopes
12.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)
12.2.2. Electromagnetic Navigation Bronchoscopy Systems
12.2.3. Pleuroscopes
12.2.4. Respiratory Endotherapy Devices
12.2.4.1. Aspiration Needles
12.2.4.2. Biopsy Forceps
12.2.4.3. Biopsy Brush
12.2.4.4. Biopsy Needles
12.2.4.5. Drainage Catheter
12.2.4.6. Pulmonary Catheter
12.2.4.7. Balloon Dilatation Catheter
12.2.4.8. Others (airway retrieval basket, airway suction catheter)
12.2.5. Airway Stents
12.2.6. Pleural Catheters
12.2.7. Endobronchial Valves
12.2.8. Bronchial Thermoplasty Systems
12.3. Market Value Forecast, by Indication, 2017–2031
12.3.1. Asthma
12.3.2. COPD
12.3.3. Lung Cancer
12.3.4. Tracheal & Bronchial Stenosis
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Diagnostic Centers
12.4.4. Specialty Clinics
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Interventional Pulmonology Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product Type, 2017–2031
13.2.1. Bronchoscopes
13.2.1.1. Flexible Bronchoscopes
13.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)
13.2.2. Electromagnetic Navigation Bronchoscopy Systems
13.2.3. Pleuroscopes
13.2.4. Respiratory Endotherapy Devices
13.2.4.1. Aspiration Needles
13.2.4.2. Biopsy Forceps
13.2.4.3. Biopsy Brush
13.2.4.4. Biopsy Needles
13.2.4.5. Drainage Catheter
13.2.4.6. Pulmonary Catheter
13.2.4.7. Balloon Dilatation Catheter
13.2.4.8. Others (airway retrieval basket, airway suction catheter)
13.2.5. Airway Stents
13.2.6. Pleural Catheters
13.2.7. Endobronchial Valves
13.2.8. Bronchial Thermoplasty Systems
13.3. Market Value Forecast, by Indication, 2017–2031
13.3.1. Asthma
13.3.2. COPD
13.3.3. Lung Cancer
13.3.4. Tracheal & Bronchial Stenosis
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Diagnostic Centers
13.4.4. Specialty Clinics
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Interventional Pulmonology Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Product Type, 2017–2031
14.2.1. Bronchoscopes
14.2.1.1. Flexible Bronchoscopes
14.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)
14.2.2. Electromagnetic Navigation Bronchoscopy Systems
14.2.3. Pleuroscopes
14.2.4. Respiratory Endotherapy Devices
14.2.4.1. Aspiration Needles
14.2.4.2. Biopsy Forceps
14.2.4.3. Biopsy Brush
14.2.4.4. Biopsy Needles
14.2.4.5. Drainage Catheter
14.2.4.6. Pulmonary Catheter
14.2.4.7. Balloon Dilatation Catheter
14.2.4.8. Others (airway retrieval basket, airway suction catheter)
14.2.5. Airway Stents
14.2.6. Pleural Catheters
14.2.7. Endobronchial Valves
14.2.8. Bronchial Thermoplasty Systems
14.3. Market Value Forecast, by Indication, 2017–2031
14.3.1. Asthma
14.3.2. COPD
14.3.3. Lung Cancer
14.3.4. Tracheal & Bronchial Stenosis
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Diagnostic Centers
14.4.4. Specialty Clinics
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Argon Medical
15.2.1.1. Company Description
15.2.1.2. Business Overview
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.2.2. Body Vision Medical Ltd.
15.2.2.1. Company Description
15.2.2.2. Business Overview
15.2.2.3. Strategic Overview
15.2.2.4. SWOT Analysis
15.2.3. Boston Scientific Corporation
15.2.3.1. Company Description
15.2.3.2. Business Overview
15.2.3.3. Financial Overview
15.2.3.4. Strategic Overview
15.2.3.5. SWOT Analysis
15.2.4. C. R. Bard, Inc. (Becton, Dickinson and Company)
15.2.4.1. Company Description
15.2.4.2. Business Overview
15.2.4.3. Financial Overview
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. CONMED Corporation
15.2.5.1. Company Description
15.2.5.2. Business Overview
15.2.5.3. Financial Overview
15.2.5.4. Strategic Overview
15.2.5.5. SWOT Analysis
15.2.6. Cook Medical
15.2.6.1. Company Description
15.2.6.2. Business Overview
15.2.6.3. Strategic Overview
15.2.6.4. SWOT Analysis
15.2.7. ENDO-FLEX GmbH
15.2.7.1. Company Description
15.2.7.2. Business Overview
15.2.7.3. SWOT Analysis
15.2.8. Fujifilm Holding Corporation
15.2.8.1. Company Description
15.2.8.2. Business Overview
15.2.8.3. Financial Overview
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9. KARL STORZ
15.2.9.1. Company Description
15.2.9.2. Business Overview
15.2.9.3. Strategic Overview
15.2.9.4. SWOT Analysis
15.2.10. Medtronic plc
15.2.10.1. Company Description
15.2.10.2. Business Overview
15.2.10.3. Financial Overview
15.2.10.4. Strategic Overview
15.2.10.5. SWOT Analysis
15.2.11. Olympus Corporation
15.2.11.1. Company Description
15.2.11.2. Business Overview
15.2.11.3. Financial Overview
15.2.11.4. Strategic Overview
15.2.11.5. SWOT Analysis
15.2.12. Pennine Healthcare
15.2.12.1. Company Description
15.2.12.2. Business Overview
15.2.12.3. SWOT Analysis
15.2.13. PENTAX Medical (HOYA)
15.2.13.1. Company Description
15.2.13.2. Business Overview
15.2.13.3. Financial Overview
15.2.13.4. Strategic Overview
15.2.13.5. SWOT Analysis
15.2.14. Pulmonx Corporation
15.2.14.1. Company Description
15.2.14.2. Business Overview
15.2.14.3. Financial Overview
15.2.14.4. Strategic Overview
15.2.14.5. SWOT Analysis
15.2.15. Richard Wolf GmbH
15.2.15.1. Company Description
15.2.15.2. Business Overview
15.2.15.3. Strategic Overview
15.2.15.4. SWOT Analysis
15.2.16. Rocket Medical plc
15.2.16.1. Company Description
15.2.16.2. Business Overview
15.2.16.3. Strategic Overview
15.2.16.4. SWOT Analysis
15.2.17. TAEWOONG
15.2.17.1. Company Description
15.2.17.2. Business Overview
15.2.17.3. SWOT Analysis
15.2.18. Vygon S.A.
15.2.18.1. Company Description
15.2.18.2. Business Overview
15.2.18.3. Strategic Overview
15.2.18.4. SWOT Analysis
List of Tables
Table 01: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031
Table 03: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 04: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 05: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 06: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 07: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 08: Global Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Region, 2017–2031
Table 09: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 10: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: North America Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031
Table 12: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 13: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 14: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 15: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Europe Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031
Table 19: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 20: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 21: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 22: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 23: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 24: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 25: Asia Pacific Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031
Table 26: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 27: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 28: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 29: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 30: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 31: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 32: Latin America Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031
Table 33: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 34: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 35: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 36: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 37: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 38: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 39: Middle East & Africa Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031
Table 40: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 41: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 42: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 43: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Interventional Pulmonology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 02: Global Interventional Pulmonology Market Volume (Thousand Units) Forecast, 2017–2031
Figure 03: Global Interventional Pulmonology Market Value Share, by Region, 2020
Figure 04: Global Interventional Pulmonology Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 05: Global Interventional Pulmonology Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 06: Global Interventional Pulmonology Market Revenue (US$ Mn), by Bronchoscopes, 2017–2031
Figure 07: Global Interventional Pulmonology Market Revenue (US$ Mn), by Electromagnetic Navigation Bronchoscopy Systems, 2017–2031
Figure 08: Global Interventional Pulmonology Market Revenue (US$ Mn), by Pleuroscopes, 2017–2031
Figure 09: Global Interventional Pulmonology Market Revenue (US$ Mn), by Respiratory Endotherapy Devices, 2017–2031
Figure 10: Global Interventional Pulmonology Market Revenue (US$ Mn), by Airway Stents, 2017–2031
Figure 11: Global Interventional Pulmonology Market Revenue (US$ Mn), by Pleural Catheters, 2017–2031
Figure 12: Global Interventional Pulmonology Market Revenue (US$ Mn), by Endobronchial Valves, 2017–2031
Figure 13: Global Interventional Pulmonology Market Revenue (US$ Mn), by Bronchial Thermoplasty Systems, 2017–2031
Figure 14: Global Interventional Pulmonology Market Value Share Analysis, by Indication, 2021 and 2031
Figure 15: Global Interventional Pulmonology Market Attractiveness Analysis, by Indication, 2021–2031
Figure 16: Global Interventional Pulmonology Market Revenue (US$ Mn), by Asthma, 2017–2031
Figure 17: Global Interventional Pulmonology Market Revenue (US$ Mn), by COPD, 2017–2031
Figure 18: Global Interventional Pulmonology Market Revenue (US$ Mn), by Lung Cancer, 2017–2031
Figure 19: Global Interventional Pulmonology Market Revenue (US$ Mn), by Tracheal & Bronchial Stenosis, 2017–2031
Figure 20: Global Interventional Pulmonology Market Revenue (US$ Mn), by Others, 2017–2031
Figure 21: Global Interventional Pulmonology Market Value Share Analysis, by End-user, 2021 and 2031
Figure 22: Global Interventional Pulmonology Market Attractiveness Analysis, by End-user, 2021–2031
Figure 23: Global Interventional Pulmonology Market Revenue (US$ Mn), by Hospitals, 2017–2031
Figure 24: Global Interventional Pulmonology Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031
Figure 25: Global Interventional Pulmonology Market Revenue (US$ Mn), by Specialty Clinics, 2017–2031
Figure 26: Global Interventional Pulmonology Market Revenue (US$ Mn), by Diagnostic Centers, 2017–2031
Figure 27: Global Interventional Pulmonology Market Revenue (US$ Mn), by Others, 2017–2031
Figure 28: Global Interventional Pulmonology Market Value Share Analysis, by Region, 2021 and 2031
Figure 29: Global Interventional Pulmonology Market Attractiveness Analysis, by Region, 2021–2031
Figure 30: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, 2017–2031
Figure 31: North America Interventional Pulmonology Market Value Share Analysis, by Country, 2021 and 2031
Figure 32: North America Interventional Pulmonology Market Attractiveness Analysis, by Country, 2021–2031
Figure 33: North America Interventional Pulmonology Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 34: North America Interventional Pulmonology Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 35: North America Interventional Pulmonology Market Value Share Analysis, by Indication, 2021 and 2031
Figure 36: North America Interventional Pulmonology Market Attractiveness Analysis, by Indication, 2021–2031
Figure 37: North America Interventional Pulmonology Market Value Share Analysis, by End-user, 2021 and 2031
Figure 38: North America Interventional Pulmonology Market Attractiveness Analysis, by End-user, 2021–2031
Figure 39: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, 2017–2031
Figure 40: Europe Interventional Pulmonology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 41: Europe Interventional Pulmonology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 42: Europe Interventional Pulmonology Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 43: Europe Interventional Pulmonology Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 44: Europe Interventional Pulmonology Market Value Share Analysis, by Indication, 2021 and 2031
Figure 45: Europe Interventional Pulmonology Market Attractiveness Analysis, by Indication, 2021–2031
Figure 46: Europe Interventional Pulmonology Market Value Share Analysis, by End-user, 2021 and 2031
Figure 47: Europe Interventional Pulmonology Market Attractiveness Analysis, by End-user, 2021–2031
Figure 48: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, 2017–2031
Figure 49: Asia Pacific Interventional Pulmonology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 50: Asia Pacific Interventional Pulmonology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 51: Asia Pacific Interventional Pulmonology Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 52: Asia Pacific Interventional Pulmonology Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 53: Asia Pacific Interventional Pulmonology Market Value Share Analysis, by Indication, 2021 and 2031
Figure 54: Asia Pacific Interventional Pulmonology Market Attractiveness Analysis, by Indication, 2021–2031
Figure 55: Asia Pacific Interventional Pulmonology Market Value Share Analysis, by End-user, 2021 and 2031
Figure 56: Asia Pacific Interventional Pulmonology Market Attractiveness Analysis, by End-user, 2021–2031
Figure 57: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, 2017–2031
Figure 58: Latin America Interventional Pulmonology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 59: Latin America Interventional Pulmonology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 60: Latin America Interventional Pulmonology Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 61: Latin America Interventional Pulmonology Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 62: Latin America Interventional Pulmonology Market Value Share Analysis, by Indication, 2021 and 2031
Figure 63: Latin America Interventional Pulmonology Market Attractiveness Analysis, by Indication, 2021–2031
Figure 64: Latin America Interventional Pulmonology Market Value Share Analysis, by End-user, 2021 and 2031
Figure 65: Latin America Interventional Pulmonology Market Attractiveness Analysis, by End-user, 2021–2031
Figure 66: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, 2017–2031
Figure 67: Middle East & Africa Interventional Pulmonology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 68: Middle East & Africa Interventional Pulmonology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 69: Middle East & Africa Interventional Pulmonology Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 70: Middle East & Africa Interventional Pulmonology Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 71: Middle East & Africa Interventional Pulmonology Market Value Share Analysis, by Indication, 2021 and 2031
Figure 72: Middle East & Africa Interventional Pulmonology Market Attractiveness Analysis, by Indication, 2021–2031
Figure 73: Middle East & Africa Interventional Pulmonology Market Value Share Analysis, by End-user, 2021 and 2031
Figure 74: Middle East & Africa Interventional Pulmonology Market Attractiveness Analysis, by End-user, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Interventional Pulmonology Market
